Randy Wu

Randy Wu is a distinguished patent litigation attorney with a focused practice in intellectual property, particularly within the life sciences sector, including genomics and spatial biology. As in-house counsel, he primarily represents companies in protecting their proprietary technologies against alleged infringers. His current role as General Counsel and Secretary at 10x Genomics, Inc., emphasizes a plaintiff-side approach in safeguarding the company's significant patent portfolio.

Prior to his appointment as General Counsel, Mr. Wu served as Vice President of Intellectual Property and Litigation at 10x Genomics since 2016. Before joining 10x Genomics, he honed his litigation skills as an attorney at Orrick, Herrington & Sutcliffe, where he specialized in intellectual property and life sciences matters. His work at 10x Genomics has involved several high-profile disputes aimed at enforcing patent rights for next-generation sequencing and spatial profiling technologies.

Notable cases include 10x Genomics' ongoing litigation against Element Biosciences, Inc., concerning spatial technology patents related to multiomic analysis platforms. He was also integral to 10x Genomics' global patent dispute with Bruker (which acquired NanoString) over spatial profiling technology, which concluded with a settlement involving payments to 10x Genomics, following a $31 million jury verdict in Delaware. Additionally, Mr. Wu has been involved in litigation against Curio Biosciences and a settlement in an intellectual property dispute with Vizgen regarding spatial transcriptomics technology.

Randy Wu's direct appearances in PTAB or IPR proceedings are not extensively highlighted in public records as a primary focus of his patent litigation practice. He holds a J.D. from Stanford Law School, a Ph.D. in Biophysics from the University of California, San Francisco, and an A.B. in Chemistry from Harvard College. He is admitted to the State Bar of California.